IPO registrations (S-1, F-1) · Registrants
Alamar Biosciences, Inc.
- SEC CIK
- 2104204 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2026-03-27, last 2026-04-16; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2026-04-17; declared effective 2026-04-16
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- DE
- Business address
- 47071 BAYSIDE PARKWAY, Fremont, CA 94538
- EIN
- 36-4899036
- Ticker
- ALMR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Alamar Biosciences, Inc. on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2026-04-16)
- Final price
- $17.00 per share, within the range (424B4 filed 2026-04-17, an initial public offering)
- Shares sold
- 11,250,000
- Gross proceeds
- $191,250,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ALMR
- Lead underwriters
- TD Securities; J.P. Morgan; BofA Securities; Leerink Partners; Stifel
- Syndicate
- Cowen
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ALAMAR BIOSCIENCES INC. Fuzzy (name and state)
- Federal award recipient: ALAMAR BIOSCIENCES, INC. Fuzzy (name and state)
- Federal award recipient: ALAMAR BIOSCIENCES, INC. Fuzzy (name and state)
- SEC filer: Alamar Biosciences, Inc. EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2026-03-27 | S-1 | S-1 (registration) | Alamar Biosciences, Inc. | 0001193125-26-129039 ↗ |
| 2026-04-13 | S-1/A | S-1/A (amendment) | Alamar Biosciences, Inc. | 0001193125-26-151891 ↗ |
| 2026-04-16 | S-1/A | S-1/A (amendment) | Alamar Biosciences, Inc. | 0001193125-26-158122 ↗ |
| 2026-04-16 | S-1MEF | S-1MEF (added securities) | Alamar Biosciences, Inc. | 0001193125-26-159789 ↗ |
| 2026-04-16 | EFFECT | EFFECT (declared effective) | Alamar Biosciences, Inc. | 9999999995-26-001218 ↗ |
| 2026-04-17 | 424B4 | 424B4 (final prospectus) | Alamar Biosciences, Inc. | 0001193125-26-161647 ↗ |
| 2026-04-20 | EFFECT | EFFECT (declared effective) | Alamar Biosciences, Inc. | 9999999995-26-001252 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | S-1/A | registration statement | $15.00–$17.00 | 9,375,000 | - | Nasdaq ALMR | 6 | primary document; range, shares headline, cover names 5 | document ↗ | |
| 2026-04-17 | 424B4 | final prospectus | $17.00 | 11,250,000 | $191,250,000 | Nasdaq ALMR | 6 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Chambers Rebecca | Director | 2 | 2026 | ||
| Chen Shiping | Director,Officer | Chief Operating Officer | 2 | 2026 | |
| Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | 2 | 2026 | ||
| Illumina Innovation Fund III GP, L.L.C. | TenPercentOwner | 2 | 2026 | ||
| Illumina Innovation Fund III, L.P. | TenPercentOwner | 2 | 2026 | ||
| Illumina Innovation Fund II, L.P. | TenPercentOwner | 2 | 2026 | ||
| Luo Yuling | Director,Officer | Chief Executive Officer | 2 | 2026 | |
| McAnear Justin J. | Officer | Chief Financial Officer | 2 | 2026 | |
| Naclerio Nicholas | Director; TenPercentOwner | 4 | 2026 | ||
| Qiming Corporate GP VI, Ltd. | TenPercentOwner | 2 | 2026 | ||
| Qiming GP VIII-HC, LLC | TenPercentOwner | 2 | 2026 | ||
| Qiming GP VIII, LLC | TenPercentOwner | 2 | 2026 | ||
| Qiming Managing Directors Fund VI, L.P. | TenPercentOwner | 2 | 2026 | ||
| Qiming Venture Partners VIII-HC, L.P. | TenPercentOwner | 2 | 2026 | ||
| Qiming Venture Partners VIII Investments, LLC | TenPercentOwner | 2 | 2026 | ||
| Qiming Venture Partners VI, L.P. | TenPercentOwner | 2 | 2026 | ||
| Ratcliffe Ian W | Director | 1 | 2026 | ||
| White Timothy Ogden | Officer | President | 2 | 2026 | |
| Witney Frank | Director | 2 | 2026 | ||
| RAGUSA ROBERT P | Director | 2 | 2026 | ||
| Brottem John L. | Officer | General Counsel | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ALAMAR BIOSCIENCES INC. | CA | State business registries | name and state |
| Federal award recipient | ALAMAR BIOSCIENCES, INC. | CA | Federal spending (USAspending) | name and state |
| Federal award recipient | ALAMAR BIOSCIENCES, INC. | CA | Federal spending (USAspending) | name and state |
| IPO registrant | @ROAD, INC | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 47071 BAYSIDE PKWY 94538 (FUZZY: a shared address, not proof of a shared organization) |
| Patent assignee | Alamar Biosciences, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | Alamar Biosciences, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Alamar Biosciences, Inc. | CA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, CA first:
- NGEN, INC. CA
- CEPHEID CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
- Bionano Genomics, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology